Since the publication of Kilian's (6) comprehensive taxonomic study of the genus Haemophilus in 1976, a great deal of interest has been shown in the biochemical characteristics of the genus. Kilian divided Haemophilus influenzae into five biotypes, primarily on the basis of production of urease, indole, and ornithine decarboxylase. He noted a relationship between some of the biotypes and the disease entity, i.e., almost all biotype I organisms were isolated from patients with acute infections, biotype II was from patients with various infections, including conjunctivitis, and from normal throats, biotype III was primarily from patients with conjunctivitis and from normal throats, and biotype V was from patients with ear infections. Other studies have shown a correlation between biotypes and clinical sources of isolation (1, 2, 4, 7, 9).
In 1979, Oberhofer and Back (10) characterized 464 strains of H. influenzae and reported their biotypes and sources of isolation. In general, their findings agreed with those of Kilian (6) . In their report, they also described a new biotype, biotype VI, which has the biochemical reactions of an unclassified group mentioned by Killian (6) in his original study. The sources of the eight biotype VI strains were the ears and nasopharynx.
Gratten (5) recently described a previously unreported biotype of H. influenzae and suggested that it be designated biotype VII. He described this biotype as ornithine decarboxylase and urease negative and indole positive. The strain he reported was isolated from the nose of a well 2-year-old child.
During the last 8 years, the Special Bacterial Pathogens Laboratory, Division of Bacterial Diseases, Centers for Disease Control, Atlanta, Ga., has received a number of H. influenzae strains that were non-serotypable with typespecific antisera a through f and could not be classified as one of Kilian's original biotypes I through V. As biotypes VI and VII have now been described, we would like to report 19 H. influenzae strains that can be classified as one of these infrequently encountered biotypes and 6 strains that we suggest be classified as a new biotype, biotype VIII. The six strains were indole, urease, and ornithine decarboxylase negative.
The factor requirements of all the strains studied were determined with plates containing heart infusion agar (Difco Laboratories, Detroit, Mich.) and Taxo Haemophilus differentiation strips (BBL Microbiology Systems, Cockeysville, Md.) by previously described methods (11) . Tests used to detect synthesis of porphyrins and production of catalase and alkaline phosphatases were the same as those described by Kilian (6) . Tests and media used to detect oxidase, urease, and indole production and reduction of nitrate to nitrite were the same as those used routinely in the Special Bacterial Pathogens Laboratory (8) . Two drops of Fildes peptic digest of blood were added to the media when required to enhance growth. Strains were tested for carbohydrate utilization by the Brown (3) modification of the rapid fermentation test.
The biochemical and physiological characteristics of the six strains that we propose be designated as biotype VIII are shown in Table 1 .
The differential characteristics of biotypes VI, VII, and VIII are shown in Table 2 . The sources of strains of biotype VI reported by Oberhofer and Back (10) were the nasopharynx and ears. We received one strain from each of these sources, one strain from the maxillary sinus, one strain from cerebrospinal fluid, and one strain from the appendix; the source was unknown for one strain. The strain that Gratten (5) described and designated as biotype VII was from the upper respiratory tract, as were 11 (10 from the throat and 1 from the maxillary sinus) of the 13 strains we examined. One of the other two strains was isolated from the cervix; the source was unknown for the other strain. All of the six strains we are proposing be designated as biotype VIII were upper respiratory tract isolates (four from the throat and two from sputum).
On the basis of three biochemical tests, a maximum of eight biotypes of H. influenzae could be described. Kilian (6) described biotypes I through V in detail, Oberhofer and Back (10) described biotype VI, Gratten (5) described biotype VII, and now we are describing the eighth and final biotype, biotype VIII, on the basis of these characteristics. Whether subbiotypes may be described on the basis of other biochemical reactions has yet to be determined.
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